Add to ORKGBackground Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral agent for patients infected with HIV-1 strains that do not harbor resistance mutations. Pres-ence of tablet remnants of NVP XR in stools was reported in 1.19 % and 3.05 % of subjects in two clinical trials. However, the prevalence may have been underestimated because the information was retrospectively collected in the studies. Methods Between April and December 2014, we prospectively inquired about the frequency of notic-ing tablet remnants of NVP XR in stools in HIV-1-infected patients who switched to antiretro-viral regimens containing NVP XR plus 2 nucleos(t)ide reverse-transcriptase inhibitors. Patients were invited to participate in th...
Background: Temporary increases in plasma HIV RNA ('blips') are common in HIV patients on ...
International audienceBACKGROUND: In resource-limited settings where nevirapine-containing regimen i...
Protease inhibitors (PIs) have been shown to have anti-tumor activity in addition to their antiretro...
Background ;Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretrovira...
Item does not contain fulltextBACKGROUND: Single-dose nevirapine is a highly cost-effective strategy...
Contains fulltext : 109788.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
*These authors contributed equally for this work. Introduction: Previous research has raised concern...
In China, HIV-1-infected patients typically receive antiretroviral therapy (ART) that includes lamiv...
Background: This study (VERxVE) compared the efficacy and safety of the new nevirapine extended-rele...
Antiretroviral (ARV) drug use was analyzed in HIV-uninfected women in an observational cohort study ...
Background Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment reg...
Objectives: To determine incidence and risk factors of nevirapine (NVP)-associated severe hepatitis ...
Background: There is strong evidence that post-exposure prophylaxis (PEP) with antiretroviral drugs ...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
Journal Article;BACKGROUND Numerous studies have shown that baseline drug resistance patterns may i...
Background: Temporary increases in plasma HIV RNA ('blips') are common in HIV patients on ...
International audienceBACKGROUND: In resource-limited settings where nevirapine-containing regimen i...
Protease inhibitors (PIs) have been shown to have anti-tumor activity in addition to their antiretro...
Background ;Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretrovira...
Item does not contain fulltextBACKGROUND: Single-dose nevirapine is a highly cost-effective strategy...
Contains fulltext : 109788.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
*These authors contributed equally for this work. Introduction: Previous research has raised concern...
In China, HIV-1-infected patients typically receive antiretroviral therapy (ART) that includes lamiv...
Background: This study (VERxVE) compared the efficacy and safety of the new nevirapine extended-rele...
Antiretroviral (ARV) drug use was analyzed in HIV-uninfected women in an observational cohort study ...
Background Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment reg...
Objectives: To determine incidence and risk factors of nevirapine (NVP)-associated severe hepatitis ...
Background: There is strong evidence that post-exposure prophylaxis (PEP) with antiretroviral drugs ...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
Journal Article;BACKGROUND Numerous studies have shown that baseline drug resistance patterns may i...
Background: Temporary increases in plasma HIV RNA ('blips') are common in HIV patients on ...
International audienceBACKGROUND: In resource-limited settings where nevirapine-containing regimen i...
Protease inhibitors (PIs) have been shown to have anti-tumor activity in addition to their antiretro...